A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EMYB SEC filings page.
EMBASSY BANCORP INC (EMYB) reported $49.2M in revenue over the twelve months to Jun 30, 2026, up 16.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 restored earnings and cash generation, but elevated interest expense and liability-heavy financing still define Embassy Bancorp's operating model.
The FY2025 earnings rebound was not driven by cheaper funding: interest expense reached$29.0M , above$18.1M in FY2023. Yet operating cash flow of$12.8M nearly matched net income of$13.7M , so the recovery was broadly cash-backed despite that cost pressure.
Assets expanded
Capital spending was only
Financial Health Signals
EMBASSY BANCORP INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
EMBASSY BANCORP INC passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, EMBASSY BANCORP INC generates $0.94 in operating cash flow ($12.8M OCF vs $13.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
EMBASSY BANCORP INC generated $13.2M in revenue in Q2 2026. This represents an increase of 15.9% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.
EMBASSY BANCORP INC reported $4.1M in net income in Q2 2026. This represents an increase of 20.0% from the same quarter a year earlier. Against the prior quarter it is up 10.3%.
EMBASSY BANCORP INC earned $0.56 per diluted share (EPS) in Q2 2026. This represents an increase of 24.4% from the same quarter a year earlier. Against the prior quarter it is up 12.0%.
Not reported for Q2 2026.
Cash & Balance Sheet
EMBASSY BANCORP INC generated $2.9M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 49.1% from the same quarter a year earlier. Against the prior quarter it is down 36.9%.
EMBASSY BANCORP INC held $132.9M in cash as of Q2 2026; long-term debt is not reported for that period.
EMBASSY BANCORP INC paid $0.55 per share in dividends in Q2 2026. This represents an increase of 14.6% from the same quarter a year earlier.
Margins & Returns
EMBASSY BANCORP INC's net profit margin was 31.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
EMBASSY BANCORP INC's ROE was 3.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
EMBASSY BANCORP INC invested $243K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 20.3% from the same quarter a year earlier. Against the prior quarter it is up 38.9%.
Not reported for Q2 2026.
Not reported for Q2 2026.
EMYB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.2M+15.9% | $12.2M+16.3% | $12.1M+17.8% | $11.7M+17.1% | $11.4M+18.4% | $10.5M+10.6% | $10.3M+8.4% | $10.0M+0.5% |
| SG&A Expenses | $3.8M0.0% | $3.9M+7.7% | $3.9M+7.5% | $3.8M+2.6% | $3.8M+10.1% | $3.6M+4.0% | $3.6M+23.0% | $3.7M+5.3% |
| Interest Expense | $7.1M-2.2% | $7.1M-0.7% | $7.2M-2.8% | $7.4M-4.5% | $7.3M+1.1% | $7.1M+11.5% | $7.4M+24.0% | $7.8M+51.6% |
| Income Tax | $869K+25.8% | $839K+35.1% | $776K+42.4% | $811K+52.7% | $691K+36.6% | $621K+27.5% | $545K-11.1% | $531K-20.4% |
| Net Income | $4.1M+20.0% | $3.7M+29.5% | $3.6M+32.7% | $3.8M+39.8% | $3.4M+37.9% | $2.9M+13.8% | $2.7M-4.3% | $2.7M-9.6% |
| EPS (Basic) | $0.56+24.4% | $0.50+31.6% | $0.47+34.3% | $0.50+38.9% | $0.45+36.4% | $0.38+15.2% | $0.35-7.9% | $0.36-7.7% |
| EPS (Diluted) | $0.56+24.4% | $0.50+31.6% | $0.47+34.3% | $0.50+38.9% | $0.45+36.4% | $0.38+15.2% | $0.35-7.9% | $0.36-7.7% |
| Diluted Shares (Avg) | 7M-3.0% | 8M-1.3% | N/A | 8M+0.4% | 8M+0.4% | 8M+0.5% | N/A | 8M+0.2% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
EMYB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9B+5.7% | $1.8B+5.0% | $1.8B+5.6% | $1.8B+3.7% | $1.8B+2.5% | $1.8B+6.1% | $1.7B+2.9% | $1.7B+2.3% |
| Cash & Equivalents | $132.9M+44.8% | $141.8M+44.9% | $112.9M+16.9% | $108.0M+17.5% | $91.8M-32.4% | $97.9M+64.5% | $96.5M+22.3% | $91.9M+18.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.7B+5.2% | $1.7B+4.6% | $1.7B+4.7% | $1.7B+3.4% | $1.6B+1.9% | $1.6B+6.0% | $1.6B+3.0% | $1.6B+0.7% |
| Total Equity | $128.1M+12.0% | $124.8M+11.0% | $127.6M+19.8% | $122.4M+6.9% | $114.3M+11.4% | $112.4M+8.3% | $106.5M+0.8% | $114.5M+33.7% |
| Retained Earnings | $137.1M+8.9% | $137.0M+8.6% | $133.3M+8.1% | $129.7M+7.6% | $125.9M+6.8% | $126.1M+6.4% | $123.3M+6.2% | $120.6M+6.5% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
EMYB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.2M+39.8% | $4.8M+80.0% | $3.9M+79.3% | $4.0M-29.6% | $2.3M+650.8% | $2.7M+48.6% | $2.2M-21.5% | $5.7M+0.2% |
| Depreciation & Amortization | $285K+6.3% | $269K+3.5% | $262K-22.3% | $275K+1.1% | $268K-0.4% | $260K-3.3% | $337K+33.7% | $272K+16.2% |
| Capital Expenditures | $243K-20.3% | $175K+124.4% | $128K-49.2% | $121K-22.9% | $305K+444.6% | $78K-71.5% | $252K+21.7% | $157K-11.3% |
| Free Cash Flow | $2.9M+49.1% | $4.7M+78.7% | $3.8M+96.2% | $3.9M-29.8% | $2.0M+697.6% | $2.6M+70.1% | $1.9M-25.0% | $5.5M+0.5% |
| Investing Cash Flow | -$18.8M-139.4% | -$17.3M+62.8% | -$14.6M-439.2% | $1.3M+103.8% | -$7.8M-150.9% | -$46.5M-118.3% | $4.3M-88.8% | -$34.6M-907.3% |
| Financing Cash Flow | $6.7M+1405.8% | $41.5M-8.3% | $15.6M+942.0% | $10.9M+172.2% | -$514K-100.8% | $45.2M+52461.6% | -$1.8M+95.4% | -$15.1M-2273.9% |
| Dividends Paid | N/A | N/A | $0 | $0 | N/A | N/A | $0 | $0 |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
EMYB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 31.3%+1.1pp | 30.8%+3.1pp | 29.5%+3.3pp | 32.3%+5.2pp | 30.3%+4.3pp | 27.6%+0.8pp | 26.2%-3.5pp | 27.1%-3.0pp |
| Return on Equity | 3.2%+0.2pp | 3.0%+0.4pp | 2.8%+0.3pp | 3.1%+0.7pp | 3.0%+0.6pp | 2.6%+0.1pp | 2.5%-0.1pp | 2.4%-1.1pp |
| Return on Assets | 0.2%0.0pp | 0.2%0.0pp | 0.2%0.0pp | 0.2%0.0pp | 0.2%+0.1pp | 0.2%0.0pp | 0.2%0.0pp | 0.2%0.0pp |
| Debt-to-Equity | 13.52-0.9x | 13.76-0.8x | 13.11-1.9x | 13.52-0.5x | 14.39-1.3x | 14.60-0.3x | 15.01+0.3x | 13.98-4.6x |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| FCF Margin | 22.3%+5.0pp | 38.3%+13.4pp | 31.0%+12.4pp | 33.0%-22.0pp | 17.3%+14.8pp | 24.9%+8.7pp | 18.6%-8.3pp | 55.0%0.0pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| EMBASSY BANCORP INC EMYB | FY2025 | $45.7M | $13.7M | 30.0% | $160.6M | — |
| QNB Corp. QNBC | FY2025 | $58.2M | $14.1M | 24.2% | $287.2M | 33/100 |
Where EMBASSY BANCORP INC Ranks
Frequently Asked Questions
What is EMBASSY BANCORP INC's annual revenue?
EMBASSY BANCORP INC (EMYB) reported $45.7M in total revenue for fiscal year 2025. This represents a 16.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is EMBASSY BANCORP INC's revenue growing?
EMBASSY BANCORP INC (EMYB) revenue grew by 16.0% year-over-year, from $39.4M to $45.7M in fiscal year 2025.
Is EMBASSY BANCORP INC profitable?
Yes, EMBASSY BANCORP INC (EMYB) reported a net income of $13.7M in fiscal year 2025, with a net profit margin of 30.0%.
What is EMBASSY BANCORP INC's net profit margin?
EMBASSY BANCORP INC (EMYB) had a net profit margin of 30.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does EMBASSY BANCORP INC pay dividends?
Yes, EMBASSY BANCORP INC (EMYB) paid $0.48 per share in dividends during fiscal year 2025.
What is EMBASSY BANCORP INC's return on equity (ROE)?
EMBASSY BANCORP INC (EMYB) has a return on equity of 10.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is EMBASSY BANCORP INC's free cash flow?
EMBASSY BANCORP INC (EMYB) generated $12.2M in free cash flow during fiscal year 2025. This represents a 32.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is EMBASSY BANCORP INC's operating cash flow?
EMBASSY BANCORP INC (EMYB) generated $12.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are EMBASSY BANCORP INC's total assets?
EMBASSY BANCORP INC (EMYB) had $1.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are EMBASSY BANCORP INC's capital expenditures?
EMBASSY BANCORP INC (EMYB) invested $632K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is EMBASSY BANCORP INC's debt-to-equity ratio?
EMBASSY BANCORP INC (EMYB) had a debt-to-equity ratio of 13.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is EMBASSY BANCORP INC's return on assets (ROA)?
EMBASSY BANCORP INC (EMYB) had a return on assets of 0.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is EMBASSY BANCORP INC's P/E ratio?
EMBASSY BANCORP INC (EMYB) trades at 10.5x earnings, its market capitalization divided by net income of $15.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $160.6M as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is EMBASSY BANCORP INC's price-to-sales ratio?
EMBASSY BANCORP INC (EMYB) trades at 3.3x sales, its market capitalization divided by revenue of $49.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $160.6M as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is EMBASSY BANCORP INC's Piotroski F-Score?
EMBASSY BANCORP INC (EMYB) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are EMBASSY BANCORP INC's earnings high quality?
EMBASSY BANCORP INC (EMYB) has an earnings quality ratio of 0.94x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.